First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: The SUSKA study, a non-randomized comparison from the VACH cohort

Literals

• bibo:issn
  • 0305-7453
• ou:eid
  • 2-s2.0-44449175504
• dcterms:contributor
• bibo:doi
  • 10.1093/jac/dkn121
• dcterms:creator
  • Domingo P.
• bibo:page_range
  • 1348-1358
• ou:urlScopus
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=44449175504&origin=inward
• vcard:url
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=44449175504&origin=inward
• bibo:eissn
  • 1460-2091
• fabio:hasPublicationYear
  • 2008
• dcterms:publisher
  • Journal of Antimicrobial Chemotherapy
• dcterms:title
  • First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: The SUSKA study, a non-randomized comparison from the VACH cohort
• vivo:identifier
  • 2008-653
• ou:tipoPublicacion
  • Article
• ou:vecesCitado
  • 29
• bibo:volume
  • 61

Typed Literals

• ou:openaccess
  • True (xsd:boolean)

Inverse Relations

• Has related: ou:tienePublicacion
  • AGUSTÍN MUÑOZ SANZ